These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17167539)

  • 1. Inactivation mechanism of the beta-ketoacyl-[acyl carrier protein] reductase of bacterial type-II fatty acid synthase by epigallocatechin gallate.
    Li BH; Zhang R; Du YT; Sun YH; Tian WX
    Biochem Cell Biol; 2006 Oct; 84(5):755-62. PubMed ID: 17167539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase.
    Zhang YM; Rock CO
    J Biol Chem; 2004 Jul; 279(30):30994-1001. PubMed ID: 15133034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase.
    Wang X; Tian W
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1200-6. PubMed ID: 11700039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activity of chlorogenic acid on enzymes involved in the fatty acid synthesis in animals and bacteria.
    Li BH; Ma XF; Wu XD; Tian WX
    IUBMB Life; 2006 Jan; 58(1):39-46. PubMed ID: 16540431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only one of the two annotated Lactococcus lactis fabG genes encodes a functional beta-ketoacyl-acyl carrier protein reductase.
    Wang H; Cronan JE
    Biochemistry; 2004 Sep; 43(37):11782-9. PubMed ID: 15362862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A substitutive substrate for measurements of beta-ketoacyl reductases in two fatty acid synthase systems.
    Sun YH; Cheng Q; Tian WX; Wu XD
    J Biochem Biophys Methods; 2008 Apr; 70(6):850-6. PubMed ID: 18201766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
    Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
    Banerjee T; Sharma SK; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cofactor-induced conformational rearrangements establish a catalytically competent active site and a proton relay conduit in FabG.
    Price AC; Zhang YM; Rock CO; White SW
    Structure; 2004 Mar; 12(3):417-28. PubMed ID: 15016358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates.
    Rendina AR; Cheng D
    Biochem J; 2005 Jun; 388(Pt 3):895-903. PubMed ID: 15715522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
    Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
    Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis.
    Sharma SK; Kumar G; Kapoor M; Surolia A
    Biochem Biophys Res Commun; 2008 Mar; 368(1):12-7. PubMed ID: 17996734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
    Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
    Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
    Williamson MP; McCormick TG; Nance CL; Shearer WT
    J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
    J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals.
    Puig T; Relat J; Marrero PF; Haro D; Brunet J; Colomer R
    Anticancer Res; 2008; 28(6A):3671-6. PubMed ID: 19189648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation.
    Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M
    Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action.
    Liang W; Fernandes AP; Holmgren A; Li X; Zhong L
    FEBS J; 2016 Feb; 283(3):446-58. PubMed ID: 26546231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.